TissueScan, Colon Cancer cDNA Array I

SKU
HCRT101
48 samples covering 5-normal, 6-Stage I, 14-IIA, 3-IIB, 1-II, 3-IIIA, 3-IIIB, 3-IIIC,5-III, 5-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Colon Cancer cDNA Array I
Clinical Info
Diagnosis Category Colon Cancer
Tissue Colon
Shipping Ambient
Description 48 samples covering 5-normal, 6-Stage I, 14-IIA, 3-IIB, 1-II, 3-IIIA, 3-IIIB, 3-IIIC,5-III, 5-IV. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2
Fan, Wang, Jiang et al
Oncogene (2021)
Cited by 37
AI Summary: OriGene’s Human Colorectal Cancer cDNA Array (HCRT101) was used in this study to assess B-Myb mRNA expression levels in colorectal cancer samples via qRT-PCR, supporting the finding of B-Myb upregulation in tumors.
Snippet: c Verification of B-Myb mRNA overexpression in colorectal cancer. Expression of B-Myb was determined using qRT-PCR with specific primers in colorectal cancer cDNA array purchased from OriGene (HCRT101). Grades: G1 and G2
DNA methylation association with stage progression of head and neck squamous cell carcinoma
Ghafarpour, Khansari, Banaei-Moghaddam et al
Comput Biol Med (2021) 134, 104473 DOI: 10.1016/j.compbiomed.2021.104473
Cited by 11
AI Summary: OriGene products, specifically the human breast and prostate cancer expression panels HCRT101 and HPRT101, were used to analyze COL6A6 gene expression as part of the study's investigation into epigenetic regulators associated with head and neck squamous cell carcinoma progression.
Snippet: COL6A6 is a gene related to Collagen VI, a ubiquitous extracellular matrix (ECM) protein, and is associated with cells' basement membranes. This gene is part of commercially available human breast and prostate cancer expression panels (HCRT101 and HPRT101;This gene is part of commercially available human breast and prostate cancer expression panels (HCRT101 and HPRT101, Origene)
LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Xiong, Wu, Dan Peng et al
Cell Death Dis (2021) 12 (1), 24 DOI: 10.1038/s41419-020-03318-8
Cited by 49
AI Summary: In this study, OriGene products including DANCR siRNA (SR320034) and MALAT1 siRNA (SR312287) were used to specifically knock down the expression of DANCR and MALAT1, enabling the authors to investigate their roles in regulating apoptosis in colorectal cancer cells.
Snippet: Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed
FigureFigureFigure
The novel lncRNA CALIC upregulates AXL to promote colon cancer metastasis
Kawasaki, Miyamoto, Oda et al
EMBO Rep. (2019) 20 (8), e47052 DOI: 10.15252/embr.201847052
AI Summary: OriGene’s colon cancer cDNA panel was used for qRT-PCR analysis to assess CALIC expression levels across different cancer stages, helping demonstrate that CALIC expression is higher in late-stage colon cancers.
Snippet: In addition, qRT-PCR analysis of a colon cancer cDNA panel (OriGene) showed that CALIC expression was higher in late stage than in early stage cancers, while no statistically significant difference was detected between CALIC expression and other factors such as
ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer
Gimeno-Valiente, Riffo-Campos, Vallet-Sánchez et al
Sci Rep (2019) 9 (1), 9339 DOI: 10.1038/s41598-019-45411-9
AI Summary: OriGene’s TissueScan cDNA array was used to analyze ZNF518B gene expression in colorectal cancer and normal tissue samples, enabling the authors to identify its up-regulation in tumors.
Snippet: The ZNF518B expression analysis in human CRC patients was first carried out with a TissueScan cDNA array (OriGene). The array used contained 5 cDNA samples from normal mucosa;the analysis of the original tissues, provided by the supplier, showed normal histological appearance. The array also contained 43 cDNA samples from CRC patients, 10 from stage I, 13 from stage II, 14 from stage III and 6 from stage IV. …
FigureFigureFigure
Cathelicidin Suppresses Colon Cancer Metastasis via a P2RX7-Dependent Mechanism
Wang, Cheng, Law et al
Mol Ther Oncolytics (2019) 12, 195-203 DOI: 10.1016/j.omto.2019.01.004
Cited by 31
AI Summary: In this study, OriGene’s Human CK20 antibody (TA801284) and TUBB3 qPCR primers (HQP064115) were used to measure protein and mRNA expression levels, respectively, helping to assess the effect of cathelicidin on colon cancer metastasis.
FigureFigureFigure
Showing 1-6 of 13 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products